Merit Medical Systems EBITDA 2010-2023 | MMSI
Merit Medical Systems ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Merit Medical Systems Annual EBITDA
(Millions of US $) |
| 2023 |
$227 |
| 2022 |
$180 |
| 2021 |
$157 |
| 2020 |
$106 |
| 2019 |
$120 |
| 2018 |
$129 |
| 2017 |
$87 |
| 2016 |
$79 |
| 2015 |
$76 |
| 2014 |
$77 |
| 2013 |
$61 |
| 2012 |
$52 |
| 2011 |
$52 |
| 2010 |
$32 |
| 2009 |
$45 |
Merit Medical Systems Quarterly EBITDA
(Millions of US $) |
| 2023-12-31 |
$61 |
| 2023-09-30 |
$62 |
| 2023-06-30 |
$54 |
| 2023-03-31 |
$50 |
| 2022-12-31 |
$54 |
| 2022-09-30 |
$42 |
| 2022-06-30 |
$46 |
| 2022-03-31 |
$38 |
| 2021-12-31 |
$46 |
| 2021-09-30 |
$40 |
| 2021-06-30 |
$33 |
| 2021-03-31 |
$39 |
| 2020-12-31 |
$43 |
| 2020-09-30 |
$27 |
| 2020-06-30 |
$8 |
| 2020-03-31 |
$28 |
| 2019-12-31 |
$23 |
| 2019-09-30 |
$24 |
| 2019-06-30 |
$38 |
| 2019-03-31 |
$35 |
| 2018-12-31 |
$33 |
| 2018-09-30 |
$39 |
| 2018-06-30 |
$33 |
| 2018-03-31 |
$24 |
| 2017-12-31 |
$28 |
| 2017-09-30 |
$15 |
| 2017-06-30 |
$26 |
| 2017-03-31 |
$18 |
| 2016-12-31 |
$25 |
| 2016-09-30 |
$15 |
| 2016-06-30 |
$22 |
| 2016-03-31 |
$18 |
| 2015-12-31 |
$18 |
| 2015-09-30 |
$18 |
| 2015-06-30 |
$22 |
| 2015-03-31 |
$18 |
| 2014-12-31 |
$24 |
| 2014-09-30 |
$21 |
| 2014-06-30 |
$16 |
| 2014-03-31 |
$15 |
| 2013-12-31 |
$20 |
| 2013-09-30 |
$17 |
| 2013-06-30 |
$15 |
| 2013-03-31 |
$10 |
| 2012-12-31 |
$10 |
| 2012-09-30 |
$15 |
| 2012-06-30 |
$14 |
| 2012-03-31 |
$13 |
| 2011-12-31 |
$11 |
| 2011-09-30 |
$11 |
| 2011-06-30 |
$15 |
| 2011-03-31 |
$15 |
| 2010-12-31 |
$10 |
| 2010-09-30 |
$0 |
| 2010-06-30 |
$12 |
| 2010-03-31 |
$10 |
| 2009-12-31 |
$11 |
| 2009-09-30 |
$12 |
| 2009-06-30 |
$12 |
| 2009-03-31 |
$11 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$4.674B |
$1.257B |
|
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|
